Shares of ImmuPharma plc (LON:IMM – Get Free Report) were up 23.5% on Friday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 4.32 ($0.05). Approximately 86,096,039 shares traded hands during mid-day trading, an increase of 204% from the average daily volume of 28,338,043 shares. The stock had previously closed at GBX 3.50 ($0.04).
ImmuPharma Stock Up 23.5 %
The company’s fifty day moving average price is GBX 1.40 and its two-hundred day moving average price is GBX 1.65. The firm has a market cap of £18.00 million, a PE ratio of -432.20 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Read More
- Five stocks we like better than ImmuPharma
- What is the S&P/TSX Index?
- 3 EV Stocks Offering Unique Alternatives to Tesla
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- What is the FTSE 100 index?
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
